Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study

Nutrition Research

Volumn 36, Issue 11, 2016, Pages 1202-1209

  Miura, Kyoko ^a   Hughes, Maria Celia B ^a   Ungerer, Jacobus PJ ^b   Green, Adèle C ^a,c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b QUEENSLAND HEALTH   (Australia)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Arachidonic acid; Biomarkers; Docosahexaenoic acid; Eicosapentaenoic acid; Linoleic acid; Omega 3 fatty acids; Omega 6 fatty acids

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; LINOLEIC ACID; UNSATURATED FATTY ACID;

ADULT; ALL CUASE MORTALITY; ARTICLE; AUSTRALIA; CHEMICAL COMPOSITION; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; GAS CHROMATOGRAPHY; HUMAN; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; AGED; BLOOD; BODY MASS; EPIDEMIOLOGY; EXERCISE; MIDDLE AGED; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); YOUNG ADULT;

ADULT; AGED; ALPHA-LINOLENIC ACID; ARACHIDONIC ACID; AUSTRALIA; BODY MASS INDEX; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; EXERCISE; FATTY ACIDS, UNSATURATED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINOLEIC ACID; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85003571664     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2016.09.006     Document Type: Article

References (57)

1. [1] Delgado-Lista, J., Perez-Martinez, P., Lopez-Miranda, J., Perez-Jimenez, F., Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 107 (2012), S201–S213.
2. [2] Mori, T.A., Dietary n-3 PUFA and CVD: a review of the evidence. Proc Nutr Soc 73 (2014), 57–64.
3. [3] Calder, P.C., Albers, R., Antoine, J.M., Blum, S., Bourdet-Sicard, R., Ferns, G.A., et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr 101:Suppl. 1 (2009), S1–45.
4. [4] Libby, P., Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 83 (2006), 456S–460S.
5. [5] Fontes, J.D., Rahman, F., Lacey, S., Larson, M.G., Vasan, R.S., Benjamin, E.J., et al. Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohort. Atherosclerosis 240 (2015), 431–436.
6. [6] Harris, W.S., Mozaffarian, D., Rimm, E., Kris-Etherton, P., Rudel, L.L., Appel, L.J., et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119 (2009), 902–907.
7. [7] Hamazaki, T., Okuyama, H., The Japan Society for Lipid Nutrition recommends to reduce the intake of linoleic acid. A review and critique of the scientific evidence. World Rev Nutr Diet 92 (2003), 109–132.
8. [8] Ramsden, C.E., Hibbeln, J.R., Majchrzak-Hong, S.F., All PUFAs are not created equal: absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohorts. Simopoulos, A., (eds.) Healthy agriculture, healthy nutrition, healthy people World Rev Nutr Diet, 2011, Karger, Basel, 30–43.
9. [9] Simopoulos, A.P., The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 233 (2008), 674–688.
10. [10] Hardman, W.E., Omega-3 fatty acids to augment cancer therapy. J Nutr 132 (2002), 3508S–3512S.
11. [11] Czernichow, S., Thomas, D., Bruckert, E., n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations. Br J Nutr 104 (2010), 788–796.
12. [12] Cantwell, M.M., Assessment of individual fatty acid intake. Proc Nutr Soc 59 (2000), 187–191.
13. [13] McNaughton, S.A., Marks, G.C., Gaffney, P., Williams, G., Green, A., Validation of a food-frequency questionnaire assessment of carotenoid and vitamin E intake using weighed food records and plasma biomarkers: the method of triads model. Eur J Clin Nutr 59 (2004), 211–218.
14. [14] Arab, L., Biomarkers of fat and fatty acid intake. J Nutr 133 (2003), 925S–932S.
15. [15] Arab, L., Akbar, J., Biomarkers and the measurement of fatty acids. Public Health Nutr 5 (2002), 865–871.
16. [16] Baylin, A., Campos, H., The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol 17 (2006), 22–27.
17. [17] Khaw, K.-T., Friesen, M.D., Riboli, E., Luben, R., Wareham, N., Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLoS Med, 9, 2012, e1001255, 10.1371/journal.pmed.1001255.
18. [18] Thiébaut, A.C.M., Chajès, V., Gerber, M., Boutron-Ruault, M.-C., Joulin, V., Lenoir, G., et al. Dietary intakes of ω-6 and ω-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer 124 (2009), 924–931.
19. [19] Daniel, C.R., McCullough, M.L., Patel, R.C., Jacobs, E.J., Flanders, W.D., Thun, M.J., et al. Dietary intake of ω-6 and ω-3 fatty acids and risk of colorectal cancer in a prospective cohort of U.S. men and women. Cancer Epidemiol Biomarkers Prev 18 (2009), 516–525.
20. [20] de Goede, J., Verschuren, W.M.M., Boer, J.M.A., Verberne, L.D.M., Kromhout, D., Geleijnse, J.M., N-6 and n-3 fatty acid cholesteryl esters in relation to fatal CHD in a Dutch adult population: a nested case-control study and meta-analysis. PLoS One, 8, 2013, e59408, 10.1371/journal.pone.0059408.
21. [21] Mozaffarian, D., Lemaitre, R.N., King, I.B., Song, X., Huang, H., Sacks, F.M., et al. Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med 158 (2013), 515–525.
22. [22] Chien, K.-L., Lin, H.-J., Hsu, H.-C., Chen, P.-C., Su, T.-C., Chen, M.-F., et al. Comparison of predictive performance of various fatty acids for the risk of cardiovascular disease events and all-cause deaths in a community-based cohort. Atherosclerosis 230 (2013), 140–147.
23. [23] Warensjö, E., Sundström, J., Vessby, B., Cederholm, T., Risérus, U., Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am J Clin Nutr 88 (2008), 203–209.
24. [24] Fretts, A.M., Mozaffarian, D., Siscovick, D.S., Sitlani, C., Psaty, B.M., Rimm, E.B., et al. Plasma phospholipid and dietary α-linolenic acid, mortality, CHD and stroke: the Cardiovascular Health Study. Br J Nutr 112 (2014), 1206–1213.
25. [25] Marklund, M., Leander, K., Vikström, M., Laguzzi, F., Gigante, B., Sjögren, P., et al. Polyunsaturated fat intake estimated by circulating biomarkers and risk of cardiovascular disease and all-cause mortality in a population-based cohort of 60-year-old men and women. Circulation 132 (2015), 586–594.
26. [26] Wu, J.H., Lemaitre, R.N., King, I.B., Song, X., Psaty, B.M., Siscovick, D.S., et al. Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. Circulation 130 (2014), 1245–1253.
27. [27] Green, A., Battistutta, D., Hart, V., Leslie, D., Marks, G., Williams, G., et al. The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: design and baseline characteristics of participants. Control Clin Trials 15 (1994), 512–522.
28. [28] Green, A., Williams, G., Nèale, R., Hart, V., Leslie, D., Parsons, P., et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 354 (1999), 723–729.
29. [29] Marks, G.C., Hughes, M.C., van der Pols, J.C., Relative validity of food intake estimates using a food frequency questionnaire is associated with sex, age, and other personal characteristics. J Nutr 136 (2006), 459–465.
30. [30] Mantzioris, E., Cleland, L.G., Gibson, R.A., Neumann, M.A., Demasi, M., James, M.J., Biochemical effects of a diet containing foods enriched with n-3 fatty acids. Am J Clin Nutr 72 (2000), 42–48.
31. [31] Fekete, K., Marosvölgyi, T., Jakobik, V., Decsi, T., Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr 89 (2009), 2070S–2084S.
32. [32] Serra-Majem, L., Nissensohn, M., Øverby, N.C., Fekete, K., Dietary methods and biomarkers of omega 3 fatty acids: a systematic review. Br J Nutr 107 (2012), S64–S76.
33. [33] Desquilbet, L., Mariotti, F., Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 29 (2010), 1037–1057.
34. [34] Greenland, S., Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 6 (1995), 356–365.
35. [35] Brenner, H., Blettner, M., Controlling for continuous confounders in epidemiologic research. Epidemiology 8 (1997), 429–434.
36. [36] Bakewell, L., Burdge, G.C., Calder, P.C., Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br J Nutr 96 (2006), 93–99.
37. [37] Laaksonen, D.E., Nyyssönen, K., Niskanen, L., Rissanen, T.H., Salonen, J.T., Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med 165 (2005), 193–199.
38. [38] Calder, P.C., Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta 2015 (1851), 469–484.
39. [39] Kaur, G., Cameron-Smith, D., Garg, M., Sinclair, A.J., Docosapentaenoic acid (22:5n-3): a review of its biological effects. Prog Lipid Res 50 (2011), 28–34.
40. [40] Skulas-Ray, A.C., Flock, M.R., Richter, C.K., Harris, W.S., West, S.G., Kris-Etherton, P.M., Red blood cell docosapentaenoic acid (DPA n-3) is inversely associated with triglycerides and C-reactive protein (CRP) in healthy adults and dose-dependently increases following n-3 fatty acid supplementation. Nutrients 7 (2015), 6390–6404.
41. [41] Mozaffarian, D., Wu, J.H.Y., (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?. J Nutr 142 (2012), 614S–625S.
42. [42] Williams, C.M., Burdge, G., Long-chain n-3 PUFA: plant v. marine sources. Proc Nutr Soc 65 (2006), 42–50.
43. [43] Burdge, G.C., Calder, P.C., Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective. Nutr Res Rev 19 (2006), 26–52.
44. [44] Fleming, J.A., Kris-Etherton, P.M., The evidence for α-linolenic acid and cardiovascular disease benefits: comparisons with eicosapentaenoic acid and docosahexaenoic acid. Adv Nutr 5 (2014), 863S–876S.
45. [45] Gerber, M., Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br J Nutr 107 (2012), S228–S239.
46. [46] Harris, W., n-3 and n-6 fatty acids reduce risk for cardiovascular disease. Bendich, A., Deckelbaum, R.J., (eds.) Preventive nutrition, 2015, Springer International Publishing, Switzerland, 255–271.
47. [47] Patterson, E., Wall, R., Fitzgerald, G.F., Ross, R.P., Stanton, C., Health implications of high dietary omega-6 polyunsaturated fatty acids. J Nutr Metab, 2012, 2012, 539426, 10.1155/2012/539426.
48. [48] Ramsden, C., Zamora, D., Leelarthaepin, B., Majchrzak-Hong, S., Faurot, K., Suchindran, C., et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ, 346, 2013, e8707.
49. [49] Al-Khudairy, L., Hartley, L., Clar, C., Flowers, N., Hooper, L., Rees, K., Omega 6 fatty acids for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev, 11, 2015, Cd011094, 10.1002/14651858.CD011094.pub2.
50. [50] Crowe, F.L., Murray Skeaff, C., Green, T.J., Gray, A.R., Serum n-3 long-chain PUFA differ by sex and age in a population-based survey of New Zealand adolescents and adults. Br J Nutr 99 (2008), 168–174.
51. [51] Lohner, S., Fekete, K., Marosvölgyi, T., Decsi, T., Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications. Ann Nutr Metab 62 (2013), 98–112.
52. [52] Childs, C.E., Romeu-Nadal, M., Burdge, G.C., Calder, P.C., Gender differences in the n-3 fatty acid content of tissues. Proc Nutr Soc 67 (2008), 19–27.
53. [53] Harris, W.S., Pottala, J.V., Varvel, S.A., Borowski, J.J., Ward, J.N., McConnell, J.P., Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients. Prostaglandins Leukot Essent Fatty Acids 88 (2013), 257–263.
54. [54] Kobayashi, M., Sasaki, S., Kawabata, T., Hasegawa, K., Akabane, M., Tsugane, S., Single measurement of serum phospholipid fatty acid as a biomarker of specific fatty acid intake in middle-aged Japanese men. Eur J Clin Nutr 55 (2001), 643–650.
55. [55] Yanagisawa, N., Shimada, K., Miyazaki, T., Kume, A., Kitamura, Y., Ichikawa, R., et al. Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area. J Atheroscler Thromb 17 (2010), 285–294.
56. [56] McNaughton, S.A., Hughes, M.C., Marks, G.C., Validation of a FFQ to estimate the intake of PUFA using plasma phospholipid fatty acids and weighed foods records. Br J Nutr 97 (2007), 561–568.
57. [57] Langsted, A., Freiberg, J.J., Nordestgaard, B.G., Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 118 (2008), 2047–2056.